USING NETWORK CLUSTERING TO PREDICT COPY NUMBER VARIATIONS
ASSOCIATED WITH HEALTH DISPARITIES

BY
Yi Jiang

Li Yang
Professor of Computer Science
(Chair)

Katherine Winters
Senior Lecturer of Computer Science
(Committee Member)

Farah Kandah
Assistant Professor of Computer Science
(Committee Member)

USING NETWORK CLUSTERING TO PREDICT COPY NUMBER VARIATIONS
ASSOCIATED WITH HEALTH DISPARITIES

BY
Yi Jiang

A Thesis Submitted to the Faculty of the University of
Tennessee at Chattanooga in Partial Fulfillment
of the Requirements of the Degree of Master:
Computer Science

The University of Tennessee at Chattanooga
Chattanooga, Tennessee
December 2014

ii

ABSTRACT

Substantial health disparities exist between African Americans and Caucasians in
the United States. Copy number variations (CNVs) are one form of human genetic
variations that have been linked with complex diseases and often occur at different
frequencies among African Americans and Caucasian populations. In this study, we
aimed to investigate whether CNVs with differential population frequencies can
contribute to health disparities from the perspective of gene networks. We inferred
network clusters from two different human gene/protein networks. We then evaluated
each network cluster for the occurrences of known pathogenic genes and genes located in
CNVs with different population frequencies, and used false discovery rates (FDRs) to
rank network clusters. This approach let us identify five clusters enriched with known
pathogenic genes and with genes located in CNVs with different frequencies between
African Americans and Caucasians. These clustering patterns predict four candidate
causal population-specific CNVs that play potential roles in health disparities.
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CHAPTER I
INTRODUCTION

1.1 Objectives of the Study
In this study, we aim to investigate the association of health disparities and
genetic variations with different population frequencies, to better understand health
disparities between African Americans and Caucasians,
Here, we propose a novel network clustering based approach to associate
population-specific copy number variations (CNVs) and health disparities. First, we
obtain human gene/protein interaction networks and partition them into gene clusters.
Second, we search pathogenic single nucleotide polymorphisms (SNPs) and populationspecific CNV loci in genome database to generate gene lists. Third, clusters are ranked
based on results of gene enrichment tests for pathogenic genes and CNV-genes. At last,
we investigate the biological significance of clusters that were ranked at first place. We
will use this approach to identify CNVs that may contribute to health disparities between
African Americans and Caucasians in diseases.

1.2 Health Disparities
Health disparities refer to differences in health status between people grouped by
social or demographic factors, such as race, gender, income or geographic region. The
differences could be in the presence of disease distribution, health outcomes, quality of
1

health care and access to health care services. In United States, health disparities between
African Americans and other racial and ethnic populations are found in life expectancy,
death rates, and health measures. Figure 1.1 shows the death rates of selected ethnicities
for five causes of death in the United States. The death rates are per 100,000 population
and age-adjusted to the 2000 census. AI, AN and PI refer to American Indian, Alaska
Native, and Pacific Islander, respectively. As we can see, the death rates of African
Americans are found higher than those of other populations in heart diseases, prostate
cancer (in male), breast cancer (in female), and diabetes (National Center for Health
Statistics 2007; National Center for Health Statistics 2013) (Figure 1.1). According to a
recent study, eliminating health disparities would have reduced direct medical care
expenditures by about $230 billion and indirect costs associated with illness and
premature death by more than $1 trillion for the years 2003 to 2006 (LaVeist et al. 2011).

Death Rate per 100,000 population
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Figure 1.1 Death rates of selected ethnicities for five causes of death in the United States.
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Many factors contribute to health disparities (American Public Health
Association). People with different socioeconomic status, such as income, education and
occupation, will have different opinions on health practice and different access to healthy
diet. People living in rural area and/or with low income will have trouble to obtain
essential health care. People in different culture will have different living style, such as
different living habit and diet, which will affect disease prevalence and health treatment
outcome.
In addition, human genetic variations (HGVs) play a significant role in health
disparities (Fine et al. 2005; Ramos & Rotimi 2009). Human genes contain information
that is required to build, regulate and maintain our bodies. HGVs are permanent changes
in human genes and may cause alterations in an individual's phenotype, from physical
properties to disease risk. According to “out of Africa” model, modern humans speciated
in Africa and then migrated to other continents of the world (Stringer & Andrews 1988).
During the migration, genetic variations occurred and kept due to random chance, natural
selection, and other genetic mechanisms, at different frequencies from region to region
(Tishkoff & Verrelli 2003). It is believed that genetic variations are the main reasons of
many diseases, and thus different occurrence frequencies can lead to differences in
disease susceptibility or resistance among various populations. Studies on associations of
genetic variations and diseases are essential to understand disease etiology and health
disparities, and are greatly advanced by the completion of the International HapMap
Project (Ramos & Rotimi 2009). With the aid of modern genome sequencing techniques,
the HapMap contains information of common human genetic variants, such as where
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these variants occur in our DNA, and how they are distributed within and among
different population, which can be used by researchers to link genetic variants to diseases.

1.3 Genome-Wide Association Studies
Genome-wide association studies (GWAS) are currently an effective approach to
identify diseases-associated genetic variations (Hirschhorn & Daly 2005; Wang et al.
2005). In GWAS, a group of diseased individuals is compared to a group of healthy
individuals for a large number of Single Nucleotide Polymorphisms (SNPs) (Clarke et al.
2011). The frequency of each allele is compared between two groups and a statistical test
is performed with a null hypothesis that no association exists between disease and the
SNP. Usually tests of millions of SNPs are carried out, which requires multiple
hypothesis testing procedures to control false positives (Dudbridge & Gusnanto 2008).
Although GWAS have revealed many disease-associated SNPs, only a few of them are
associated with moderate or large increase in disease risk, and some well-known genetic
risk factors have been missed (Williams et al. 2007). One possible reason is that GWAS
focus only on individual genetic variations and do not address complex gene interactions
(Moore & Williams 2009). Another possible reason is that the current statistical analysis
is “unbiased”, since it ignores available knowledge of disease pathobiology (Moore et al.
2010).
Several approaches tried to incorporate GWAS results with known biological
knowledge. One of them is called Gene Set Analysis (GSA) (Cantor et al. 2010; Lehne et
al. 2011; Wang et al. 2007), which associates variations in an entire set of genes with a
phenotype. A gene set is defined as a set of genes that are involved in common biological
4

processes or pathways, or as a set of interacting proteins identified from protein-protein
interaction networks (Lehne et al. 2011). In GSA, enrichment tests are performed by
comparing the frequency of significantly associated SNPs in a particular set of genes with
that among all other genes not in the set. Gene sets containing significantly more
associated SNPs will have closer association with the corresponding phenotypes. The
advantage of GSA is that it detects associations of the phenotype with a gene set, not
individual SNPs. Therefore it does not ignore SNPs that have low p-values but still
contribute to phenotypes, and it reduces the number of statistical tests and requires less
stringent multiple testing correction (Lehne et al. 2011).

1.4 Copy Number Variations
Unlike SNPs, which affect only one single nucleotide base, copy number
variations (CNVs) are duplications or deletions of relatively large genomic segments that
can contain one or more genes (Feuk et al. 2006; Freeman et al. 2006). The widespread
presence of CNVs in normal individuals was first reported in 2004 (Iafrate et al. 2004;
Sebat et al. 2004). And to date, over 100,000 non-overlapping human CNVs have been
identified, with the size varying from 50 base pair to more than one million bases pairs,
and they cover about 70% of the whole genome (MacDonald et al. 2014).
In early genetic association studies, CNVs have been associated with various
complex diseases (Feuk et al. 2006; Ionita-Laza et al. 2009). Updates on CNVs’ roles in
some diseases, such as psychoses (Lee et al. 2012), autism (Wang et al. 2013),
autoimmunity (Olsson & Holmdahl 2012) and schizophrenia (Hosak et al. 2012), have
been reviewed recently. Computational tools and methods have been developed to help
5

address the potential roles of CNVs in human diseases. The CNVannotator was
developed to provide considerable capabilities for researchers to annotate specific CNVs
in a reliable and efficient manner (Zhao & Zhao 2013). The NETBAG+ algorithm was
developed to search for strongly cohesive gene clusters affected by CNVs, using a
likelihood network constructed based on a combination of various functional descriptors.
(Gilman et al. 2012). Recently, it is reported that CNVs can occur at different frequencies
between African Americans and Caucasians (McElroy et al. 2009), and naturally the
question about the potential roles of CNVs in health disparity is raised.

1.5 Protein-Protein Interaction Networks
Protein-protein interactions (PPIs) play diverse roles in biology. It is observed that
proteins seldom carry out their function in isolation, and usually proteins involved in the
same cellular processes interact with each other (von Mering et al. 2002). Advanced
high-throughput technologies, such as yeast-two-hybrid screening, mass spectrometry,
and protein microarray chip technologies, have generated huge data sets of proteinprotein interactions (von Mering et al. 2002).
Several databases have been constructed as repositories for experimentally
discovered protein interactions (Mathivanan et al. 2006). PPIs are incorporated into PPI
databases through curation from the literatures by biologists, or through direct deposit by
the investigators before their publication. For example, Human Protein Reference
Database (HPRD) is a joint project between the Institute of Bioinformatics in Bangalore,
India and the Pandey lab at Johns Hopkins University in Baltimore, USA. HPRD
contains annotations related to human proteins based on experimental evidence from the
6

literature (Mishra et al. 2006; Peri et al. 2004; Prasad et al. 2009). HPRD includes not
only PPIs, but also interactions between proteins and other small molecules, as well as
information about post-translational modifications, subcellular localization, protein
domain architecture, tissue expression and association with human diseases. PPIs in
HPRD are usually direct physical interactions. Pairwise interactions are often represented
by undirected links in a graph model of network. Some databases contain indirect genetic
or regulatory interactions, and some contain directional interactions such as those in
phosphorylation, metabolic, signaling and regulatory networks. In one study, various
interaction data have been put together to construct a unified global network named
MultiNet (Khurana et al. 2013).
Protein-protein interaction (PPI) data can be represented in the form of networks,
in which nodes are proteins and edges are interactions. The protein-protein interaction
network (PPIN) can help understand the basic scheme of cell functions by correlating the
components of the network with their cellular functions, which can be done by clustering
processes (Lin et al. 2007; Pizzuti et al. 2012; Wang et al. 2010). In PPIN, a cluster is a
set of genes that share a large number of interactions, and the clustering process is to
group genes into clusters which contain more interactions among genes in the same
cluster than in different clusters. Clustering process can identify both protein complexes
and functional modules (Lin et al. 2007; Pizzuti et al. 2012; Wang et al. 2010). Protein
complexes are groups of proteins that bind to each other at the same time and place,
while functional modules consist of proteins that participate in the same cellular process
through interactions between themselves at a different time and place. Usually the PPINs
do not contain information about when and where proteins interacts, therefore protein
7

complexes and functional modules are not treated differently in clustering processes. The
results of clustering process of PPINs can help to infer the principal function of each
cluster from the functions of its members, and suggest possible functions of cluster
members based on the functions of other members.
Many distance-based or graph-based clustering algorithms were developed to
cluster PPINs (Lin et al. 2007; Pizzuti et al. 2012; Wang et al. 2010). The Markov
Clustering (MCL) algorithm is a fast, scalable, and unsupervised clustering algorithm,
which simulates stochastic flows in graphs (van Dongen 2000). The algorithm simulates
random flows within a graph by alternation of two operations called expansion and
inflation. In expansion, the flow moves within the same dense regions or out to other
dense regions. The inflation operation strengthens the flow within the dense regions and
weakens the flow out of the dense regions. The expansion and inflation steps are repeated
until a steady state is reached. A recent study compared MCL with other three clustering
algorithms, restricted neighborhood search clustering (RNSC), super paramagnetic
clustering (SPC) and molecular complex detection (MCODE), on six PPINs to detect
previously annotated gene clusters (Brohee & van Helden 2006). The conclusion was that
MCL algorithm outperformed the other algorithms in the extraction of complexes from
interaction networks.

1.6 Network-Based Analysis
Gene/Protein interaction networks combined with GWAS data can help
understand complex biological activities and cellular mechanisms of complex diseases
(Barabasi et al. 2011; Halldorsson & Sharan 2013; Sharan et al. 2007; Vidal et al. 2011;
8

Wang et al. 2011). This is based on the assumption of “guilt by association”, which
means that genes associated with the same or related functions or diseases tend to interact
with each other and cluster together with high connectivity in networks (Altshuler et al.
2000; Oliver 2000).
One example of using PPIN to identify disease-associated genes was reported in a
study of incident Coronary Heart Disease (CHD) (Jensen et al. 2011). In this study, an
experiment-derived PPI database InWeb was used to produce unbiased protein complexes
and corresponding gene sets, which were then ranked based on results of enrichment tests
of CHD-associated genes. In the identified gene set, five out of 19 genes were involved in
abnormal cardiovascular system physiological features, and pathways related to blood
pressure regulation were significantly enriched.
Another methodology that utilizes the PPINs to discover disease associated
clusters is called the pathway and network oriented GWAS analysis (PANOGA), which
combines GWAS data with current knowledge of biochemical pathways, PPINs, and
functional and genetic information of selected SNPs (Bakir-Gungor & Sezerman 2011).
In their study, genes related to significant SNPs from GWAS data were identified and
were assigned with functional attributes, which were used in the process of identifying
clusters associated with the disease. Then, genes in one identified cluster were tested
whether they are part of important pathways. The application of this methodology on
Rheumatoid Arthritis (RA) dataset identified new RA-associated pathways, in addition to
pathways previously identified by GWAS analysis. The newly identified pathways were
found to include many genes that are known to be used as drug targets for the treatment
of RA. Moreover, new genes have been identified to be associated with RA.
9

Protein interactions could provide important clues to help illustrate SNP’s
functional association (Huang et al. 2010). Protein interaction network was combined
with other traditional hybrid features, such as sequence, structure and pathway properties,
and it was used to establish predictors using hundreds of those features. These predictors
can correctly identify around 80% of known disease-associated SNPs and is valuable to
predict undiscovered disease-associated SNPs.
In another approach, a genome-scale functional gene network, named HumanNet,
was constructed by incorporating gene expression, protein interaction, sequence and other
genomic data to prioritize candidate disease genes, which can facilitate both seed genebased and GWAS-based disease association studies (Lee et al. 2011). In seed gene-based
approach, gene connections in the network were assigned with weights, calculated by
using label propagation algorithms based on their distance to the seed genes. Genes
connected to seed genes with larger weights were be considered as more likely to be
associated with target diseases. Although for GWAS data there are no definite seed genes,
this approach can still boost the power of association analysis by using a different ranking
score (Lee et al. 2011). In the analysis of Crohn’s disease and type 2 diabetes, the
HumanNet not only boosted the identification of correct associations, but organized the
associated genes into processes, which arouse attentions to genes that were not
significantly identified in GWAS.

1.7 Contributions of the Study
Although genetic factors play a crucial role in health disparities, only a few
association studies have been reported in common complex diseases, such as breast
10

cancer (Long et al. 2013), prostate cancer (Bensen et al. 2014; Bensen et al. 2013; Xu et
al. 2011), type 2 diabetes (Ng et al. 2014) and vascular diseases (Wei et al. 2011). In
order to better understand health disparities between African Americans and Caucasians,
we aim to investigate the association of health disparities and genetic variations with
different population frequencies.
Here, we propose a novel network clustering based approach on CNVs for health
disparities. First, we choose to focus on CNVs. Although CNVs are one important type of
genetic variations, and can occur at different frequencies among African Americans and
Caucasians, no association studies have been reported so far to our best knowledge.
Therefore, this work is the first study on association of CNVs and health disparities.
Second, our approach is on gene level, and pathogenic SNPs and population specific
CNV loci are mapped to corresponding gene names. Current GWAS on health disparities
still focused on individual SNPs, but we choose to focus on genes, because only a small
fraction of the genetic heredity of most diseases can be explained by the SNPs, and a
gene-based approach can allow us using the information encoded by protein interaction
networks (Lee et al. 2011). Third, association analysis in our approach uses gene clusters
inferred from gene networks, which is based on the rationale that interacting genes often
have the same functions or participate in the same biological processes. In addition,
unlike common Gene Set Analysis (GSA) studies that compares significantly associated
SNPs (Cantor et al. 2010; Lehne et al. 2011; Wang et al. 2007), our novel approach
compares the frequency of pathogenic genes or population specific CNV related genes
between clusters to evaluated the relationship between clusters and diseases or CNVs.

11

CHAPTER II
MATERIALS AND METHODS

This chapter introduces materials (gene/protein networks and gene sets) we
collected and prepared for this study, and methods we used in clustering process, cluster
analyses and biological significance analysis.
Our overall work flow is shown in Figure 2.1. To identify potential CNVs
associated with health disparities, our basic idea is to identify gene clusters that are
enriched with both pathogenic genes and genes located in population-specific CNVs.
Health disparities in diseases associated with identified clusters could be considered as
results of the occurrence of corresponding CNVs. Specifically, we first obtained two
human gene/protein networks and partitioned them into gene clusters. We then identify
disease-associated genes and genes located in population-specific CNVs in those clusters.
Statistical tests were performed on each cluster to estimate its significances of containing
pathogenic genes and genes in population-specific CNVs. Finally, we ranked gene
clusters based on false discovery rates (FDRs). Top-ranked clusters were enriched both
for pathogenic genes and for genes in CNVs with differential frequencies between
African-Americans and Caucasians. These clusters were then searched for enriched Gene
Ontology (GO) terms and related disease phenotypes to identify corresponding biological
significance.

12

Figure 2.11 Overview of our approach to identify CNVs associated with health disparities

2.1 Network Clustering
otein
We obtained two human gene/protein networks, one from Human Protein
Reference Database (HPRD) (Mishra et al. 2006; Peri et al. 2003; Prasad et al. 2009)
2009 and
another from MultiNet (Khurana
Khurana et al. 2013
2013). The HPRD network (referred to as
HPRDNet) is one of the largest human gene/protein interaction networks, and contains
only physical protein-protein
protein interactions (PPIs)
(PPIs). The MultiNet is a unified network
including PPI, phosphorylation, metabolic, signaling, genetic and regulatory networks.
These two networks share 8468 genes (89.6% of HPRDNet and 58.6% of MultiNet) but
only 8769 interactions (23.8% of HPRDNet and 8% of MultiNet). These two networks
were both partitioned into gene clusters using the M
Markov Cluster (MCL) Algorithm (van
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Dongen 2000). MCL (version10-201) was installed and run in an Ubuntu 11.10 system.
The following command was used to run clustering:
mcl <network> --abc -I <I value> --force-connected=y -o <result>
Option <network> refers to the input file that contains the gene/protein interaction
network. In the input file, each line contains a pair of gene names, separated by a tab
space, which represent a gene-gene interaction. Option <I value> refers to the inflation
parameter I, which was from 1.1 to 2.0 with a step of 0.1. Option <result> refers to the
output file to which the clustering results will be saved. In the output file, each line
contains a set of gene names separated by a tab space, which are member of a cluster.

2.2 Gene Mapping of CNVs and SNPs
Two sets of genes were used in this study: genes located in population-specific
CNVs and pathogenic genes. Currently, there are no ready-made sources containing
information of these genes. However, coordinates of disease-associated SNPs and
population-specific CNVs were available and were searched in the UCSC Genome
Database (Karolchik et al. 2014) through its MySQL API to obtain the corresponding
gene name sets. All works were done using codes in Java. The following Java statements
were used to establish the connection to UCSC Genome Database MySQL interface:
// setup connection to UCSC Genome Database
String username = "genome";
String password = "";
String url = "jdbc:mysql://genome-mysql.cse.ucsc.edu/hg19";
Class.forName("com.mysql.jdbc.Driver");
Connection con = DriverManager.getConnection(url, username,
password);

14

CNV coordinates were obtained from a CNV map in African Americans and
Caucasians (McElroy et al. 2009). There are three types of CNVs in this map: (1) CNVs
only occur in African Americans, (2) CNVs only occur in Caucasians, and (3) CNVs
occurred in both African Americans and Caucasians. To simplify the analysis, we further
partitioned the last type: CNVs that occurred more than 50% in African Americans or in
Caucasians were combined with the first and second types of CNVs, respectively. This
repartition resulted in two modified CNV sets with differential population frequencies.
The coordinates of these CNVs were then searched in the UCSC Genome Database
through its MySQL API to obtain the corresponding gene sets. The SQL statements were
formed in Java codes (APPENDIX A) and submitted, in which begin, end, and chrom
refer to the starting positions, ending positions and chromosomes of the CNVs,
respectively:
// search related genes of CNVs
select distinct X.geneSymbol, G.chrom, G.txStart, G.txEnd
from knownGene as G, kgXref as X
where ((G.txStart>begin AND G.txEND<end or
(G.txStart>begin AND G.txStart<end or
(G.txEND>begin AND G.txEND<end or
(G.txStart<begin AND G.txEnd>end AND
X.kgId = G.name AND G.chrom = chrom);

For simplicity, CNVs that occur more frequently in African Americans were called
African-American CNVs or CNV_AA; CNVs that occur more frequently in Caucasians
were called Caucasian CNVs or CNV_CA.
Disease-associated SNPs were retrieved from a file, OmimVarLocusIdSNP.bcp,
obtained from the FTP site of Single Nucleotide Polymorphism Database (dbSNP)
(Sherry et al. 2001). Coordinates of these SNPs were then queried against the MySQL
15

API of the UCSC Genome Database to identify genes in which those SNPs are located.
The following SQL statements were composed in Java codes (see APPENDIX A) and
submitted, in which SNP refers to the RSid of the SNPs:
//search related genes of SNPs.
select distinct S.name, X.geneSymbol
from snp138 as S, knownGene as G, kgXref as X
where S.name = SNP AND
X.kgId = G.name AND S.chrom = G.chrom AND
G.txStart <= S.chromStart AND G.txEnd >= S.chromEnd;

This identified gene set was termed as pathogenic genes.

2.3 Cluster Analyses
Clusters were obtained from both HPRDNet and MultiNet using MCL with a
range of ten inflation parameters. For each cluster, contingency tables were constructed
using the numbers of pathogenic genes and population-specific CNV-related genes.
Table 2.1 is for pathogenic significance test, and Table 2.2 is for tests of enrichment
significance of CNVrelated genes (CNV_AA or CNV_CA genes). Q and q are the
number of pathogenic genes in the whole networks and that in current cluster,
respectively. N and m are the number of genes in whole networks and that in current
cluster, respectively. S and s are the number of CNV_AA or CNV_CA genes in the
whole networks and that in current cluster, respectively.
In statistics, a contingency table is a type of table that displays the frequency
distribution of multiple variables, usually in a two by two format. The significance of the
difference between the two proportions (derived based on observed frequencies) can be
evaluated by various statistical tests, such as Pearson's chi-squared test and Fisher's exact
16

test. If the proportions in the different columns are significantly different between rows
(or vice versa), we say that there is a contingency between the two variables. In our case,
we want to know whether a cluster contains more pathogenic genes or populationspecific CNV-related genes than all of the other clusters. If it does, we say this cluster is
enriched with such genes and thus has stronger connections to diseases or is more likely
to be affected by population-specific CNVs. If a cluster is found to be significant in both
enrichment tests, it will be of most interest to us.

Table 2.1
Contingency table for Fisher’s exact test on pathogenic genes
Pathogenic Genes Non-pathogenic Genes Total
q
m-q
m
Genes in this cluster
Q-q
N-Q-m+q
N-m
Genes in other clusters
Q
N-Q
N
Total

Table 2.2
Contingency table for Fisher’s exact test on CNV genes
CNV Genes Non-CNV Genes Total
s
m-s
m
Genes in this cluster
S-s
N-S-m+s
N-m
Genes in other clusters
S
N-S
N
Total

In this study, right-tailed Fisher’s exact tests were applied to these contingency
tables to calculate enrichment significance of pathogenic genes, CNV_AA or CNV_CA
genes, respectively. Fisher's exact test is a statistical test used in the analysis of
17

contingency tables. It is valid for all sample sizes, but in practice it is employed mostly
when sample sizes are small, which is the main reason it is chosen in for our analyses.
Using Table 2.1 as an example, the null hypothesis H0 is that the proportion of
pathogenic genes in one cluster less than or equals to that in all other clusters, and the
alternative hypothesis H1 indicates that this pathogenic occurrence in this cluster is more
than random expectation:
 :









 :









in which Q and q are the number of pathogenic genes in the whole networks and that in
current cluster, respectively, and N and m are the number of genes in whole networks and
that in current cluster, respectively. In other words, if the null hypothesis is true, we
would have




×

The question we ask is: what is the probability that the observed q value is larger than the
expected value in the null hypothesis? The right-tailed Fisher’s exact test will give the
answer: if the p-value is small (common cutoff values are 0.001, 0.01, 0.05, or 0.10), we
can say that in this cluster pathogenic genes were significantly enriched. The smaller the
p-values, the more significant the enrichment is. The right-tailed Fisher’s exact tests were
performed in the R statistical environment (R Development Core Team 2013), with the
following R statements composed in Java codes (see APPENDIX B) and submitted to the
R engine:
18

// pathogenic gene enrichment tests.
cluster = c(q, m-q);
other = c(Q-q, N-Q-m+q);
tb = rbind(cluster, other);
fisher.test(tb, alternative="greater")$p.value;
// population-specific CNV-related gene enrichment tests.
cluster = c(s, m-s);
other = c(S-s, N-S-m+s);
tb = rbind(cluster, other);
fisher.test(tb, alternative="greater")$p.value;

The right-tailed Fisher’s exact tests were performed to each cluster in each
clustering results, which led to the multiple comparisons problem. The multiple
comparisons problem, or multiple testing problem, occurs when a set of statistical tests
are performed simultaneously (Miller 1981), in which the null hypothesis are more likely
to be incorrectly rejected based on individual tests when all tests were considered as a
whole. The False discovery rate (FDR) control is a statistical method to correct for
multiple comparisons. In a list of tests, FDR procedures are designed to control the
proportion of incorrectly rejected null hypotheses, i.e. “false discoveries” (Benjamini &
Hochberg 1995). There are many statistical procedures that use p-values to estimate or
control the FDR, such as Benjamini-Hochberg procedure (Benjamini & Hochberg 1995)
and Q-value procedure (Storey et al. 2004). However, most of them assume that p-values
are continuously distributed and based on two-sided tests. Therefore, it is difficult to
reliably estimate the FDR when the p-values are discrete or based on one-sided tests.
Since p-values in our study are discrete and based on one-sided tests, a proper FDR
calculation procedure needs to be carefully chosen. The Robust FDR Routine does not
rely on the assumptions that tests are two-sided or yield continuously p-values, and was
shown to have excellent performance in a series of data (Pounds & Cheng 2006). Based
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on obtained p-values from the right-tailed Fisher’s exact tests, we calculated FDRs using
the Robust FDR Routine in the R statistical environment. The following R statements
were composed in Java codes (see APPENDIX C) and submitted to the R engine:
// Run robust FDR routine.
// p is the vector of all sorted p-values.
robust.fdr(p, discrete=T, use8=F)$fdr";

Ranking were applied to clusters with p-value<0.10 and FDR<0.20 in both
enrichment tests for pathogenic genes and population-preferred CNVs genes. Assuming
both tests are independent, the FDR values were multiplied and the products were used to
rank the network clusters.
The same cluster analysis procedure was applied to each clustering results with
different MCL inflation parameters. For clarity, we focused our biological significance
analyses on clusters that were consistently ranked at the first place with different MCL
inflation parameter values.

2.4 Biological Significance Analyses
To understand the biological significance of the clusters, their corresponding
Gene Ontology (GO) terms were analyzed. Gene ontology is a project to unify the
representation of gene and gene product attributes (Gene Ontology Consortium 2008).
More specifically, the project aims to develop and maintain the vocabulary of gene and
gene product attributes, annotate genes and gene products, and provide tools for data
access and functional interpretation. GO terms describe properties of genes and their
products and are grouped into three domains: cellular component (where they locate),
molecular function (what they do at the molecular level), and biological process (which
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molecular events they participate). One of the main uses of the GO terms is to perform
enrichment analysis on gene sets by comparing one target gene set to the background
gene set. If a GO term appears more often in the target gene set than in the background
gene set, it is said to be enriched in this gene set, or this gene set is highly related to this
GO term, which could help to understand the underlying biological relevance.
In this study, biological relevance of selected network clusters were analyzed by
the Gene Ontology enrichment analysis and visualization tool, or GOrilla (Eden et al.
2009) to search for enriched GO terms. In GOrilla search, genes in the selected clusters
were target genes, and all other genes in the network were treated as background genes.
To investigate the possible links of population-specific CNVs to heath disparities, we
first identified significantly enriched GO terms that are associated with CNV_AA or
CNV_CA genes. We then focused on the pathogenic genes associated with the enriched
GO terms, and examined their related disease phenotypes in OMIM database (Online
Mendelian Inheritance in Man 2014). These disease phenotypes were searched for
reported health disparities between African American and Caucasian populations.
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CHAPTER III
RESULTS AND DISCUSSION

This chapter shows our results in network clustering, gene mapping and cluster
analyses, and discusses the plausible links of population-specific CNVs in the identified
network clusters to health disparities.

3.1 Network Clustering Results
Two gene/protein interaction networks were chosen in this study: HPRDNet and
MultiNet. For HPRDNet, three types of interactions were removed before clustering
process: 1) interaction between same gene; 2) interaction involving unknown genes; 3)
and interactions with ambiguous genes. For MultiNet, all interactions were submitted to
clustering process. Clusters were inferred using MCL with ten different inflation values.
Descriptive statistics of the two networks and their clustering results are summarized in
Table 3.1. When inflation parameter I was increased, the cluster sizes decreased and the
cluster numbers increased. This is because higher I value increases the granularity or
tightness of clusters. The “--force-connected=” option is also proven to have an effect on
clustering results for both networks. When this option was set to “N”, we identified
several uninformative clusters with some genes do not connect to any other genes in the
same cluster.
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Table 3.1
Summary of biological networks
Cluster Sizes
Inflation
Total
Value
Clusters Maximum Minimum Median Mean
1.1
111
9203
2
2
85
HPRDNet:
1.2
128
9025
1
2
74
9451 genes
1.3
363
3454
1
3
26
36880 interactions
1.4
660
432
1
5
14
1.5
1036
260
1
4
9
1.6
1401
192
1
3
7
1.7
1704
152
1
3
6
1.8
1990
146
1
3
5
1.9
2222
119
1
3
4
2.0
2447
90
1
3
4
1.1
21
14399
2
2
450
MultiNet:
1.2
22
14394
2
2
430
14445 genes
1.3
43
13614
1
2
220
109598 interactions
1.4
226
5560
1
3
42
1.5
600
3524
1
2
16
1.6
923
2402
1
2
10
1.7
1387
1589
1
2
7
1.8
1660
1215
1
2
6
1.9
1887
996
1
2
5
2.0
2116
804
1
2
4
Network

3.2 Gene Mapping Results
Chromosome coordinates of pathogenic SNPs and population-specific CNVs
were searched in the UCSC Genome Database. Totally 2810 pathogenic genes, 194
CNV_AA genes and 258 CNV_CA genes were obtained. Since this study focuses on
network-derived gene clusters, only genes that are listed in HPRDNet or MultiNet were
kept. Details of gene mapping results are shown in Table 3.2.
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Table 3.2
Results of gene mapping of SNPs and CNV coordinates
Pathogenic Genes CNV_AA CNV_CA
2810
194
258
Total
1791
48
62
in HPRDNet
2143
64
97
in MultiNet

3.3 Cluster Analysis Results
We performed cluster analyses on each of the ten clustering results for both
HPRDNet and MultiNet. Ranking were applied only to clusters with p-value<0.10 and
FDR<0.20 in both enrichment tests for pathogenic genes and those for populationpreferred CNVs genes. The products of FDRs of both enrichment tests were used to rank
the network clusters.
The ranking results are listed in Table 3.3 and Table 3.4. The value of inflation
parameter I used in clustering process is from 1.1 to 2.0, increased by 0.1. Cluster NO is
the serial number of a cluster. CNV_AA and CNV_CA are CNV-related genes. Cluster
Names are names of clusters selected for biological significance analyses. p_CNV and
FDR_CNV, and p_OMIM and FDR_OMIM are p-values and FDR values from
enrichment tests for CNV-related genes and pathogenic genes, respectively. FDR product
is the multiplication result of FDR_CNV and FDR_OMIM and is used for ranking.
We focused on clusters that were consistently ranked at the first place with
different MCL inflation parameter values for further biological significance analyses. It is
worth to mention that clusters containing gene CYP2E1 were filtered out, although in
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HPRDNet these clusters have been ranked three times at first place in cluster ranking for
CNV_AA gene enrichment tests, and three times at first place for CNV_CA gene
enrichment tests (Table 3.3). This is because gene CYP2E1 is affected by multiple CNVs
and these CNVs have different population preferences. CYP2E1’s location was compared
with those CNVs’ loci. It is found that CYP2E1 is located in the overlapped region
among those CNVs, which means it may not have CNV-caused population-preferred
variations, and may not contribute to health disparities. Therefore, clusters containing
gene CYP2E1 were not included in the following analysis, and the corresponding clusters
ranked at second place were selected instead.
Details of selected clusters are listed in Table 3.5, and their graph representations
are shown in Figure 3.1. In Figure 3.1, each rounded rectangle represents a gene and each
gray line represents a gene-gene interaction. Black rounded rectangles represent nonpathogenic genes and orange rounded rectangles represent pathogenic genes. Genes
labeled with red or blue ovals are located in African American CNVs or in Caucasian
CNVs. Genes with Green lines share the same GO terms. In each cluster, different line
types represent the enrichment of different GO terms. Line types shown in different
clusters refer to the enrichment of different GO terms. The CNV_AA or CNV_CA genes
in the selected clusters and the details of their corresponding CNVs are listed in Table 3.6.
In Table 3.6, Chr represents chromosomes. CNV Regions are regions of CNVs identified
in more than a single individual. All CNVs listed have a type of Duplication, referring to
one copy increase. CNV Regions and Types are from the CNV map (McElroy et al.
2009). CNV Occurrence describes in CNVs occurrence in African American and
Caucasian populations.
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Table 3.3
Top-ranked clusters from HPRDNet
I
1.1
1.2
1.3
1.4
1.5

1.6

1.7
1.8

1.9
2.0

Cluster Cluster
CNV_AA CNV_CA OMIM Size p_CNV
No
Name
175
AA1
HSPB1
8
11 0.0534
190
AA1
HSPB1
8
11 0.0534
187
CYP2E1
5
11 0.0534
429
CA1
ATP2A1
4
5
0.0324
271
SLC4A4
5
8
0.0513
257
CRX
5
9
0.0575
162
AA2
HSPB1
8
12 0.0581
181
CYP2E1
5
11 0.0534
470
CA1
ATP2A1
4
5
0.0324
392
SLC4A4
4
6
0.0387
142
AA2
HSPB1
8
12 0.0581
509
CA1
ATP2A1
4
5
0.0324
444
CYP2E1
5
6
0.0295
109
AA3
HSPB1
8
13 0.0628
444
CYP2E1
5
6
0.0387
516
CA1
ATP2A1
4
5
0.0324
430
CYP2E1
5
6
0.0295
430
CYP2E1
5
6
0.0387
412
CYP2E1
5
6
0.0295
412
CYP2E1
5
6
0.0387
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FDR_CNV p_OMIM FDR_OMIM
0.1548
0.1032
0.1032
0.1094
0.1241
0.1260
0.0964
0.0936
0.0896
0.1007
0.0842
0.0690
0.0628
0.0889
0.0781
0.0756
0.0246
0.0684
0.0241
0.0470

1.56E-4
1.56E-4
0.0408
0.0055
0.0082
0.0155
3.91E-4
0.0408
0.0055
0.0139
3.91E-4
0.0055
0.0012
8.48E-4
0.0012
0.0055
0.0012
0.0012
0.0012
0.0012

3.78E-6
1.45E-5
0.1772
1.80E-5
4.01E-4
0.0155
4.08E-5
0.1796
0.0369
0.1238
0.0454
0.1989
0.1231
0.1010
0.1231
0.1910
0.1171
0.1171
0.1594
0.1594

FDR
product
5.85E-07
1.50E-06
1.83E-02
1.97E-06
4.98E-05
1.95E-03
3.93E-06
1.68E-02
3.31E-03
1.25E-02
3.82E-03
1.37E-02
7.73E-03
8.98E-03
9.61E-03
1.44E-02
2.88E-03
8.01E-03
3.84E-03
7.49E-03

Table 3.4
Top-ranked clusters from MultiNet
I
1.1
1.2
1.3
1.4
1.5
1.6
1.7
1.8

1.9

2.0

Cluster Cluster
CNV_AA
CNV_CA OMIM Size p_CNV FDR_CNV p_OMIM
No.
Name
30
ANXA8, IGHG1
12
46 0.0176
0.1588
0.0326
85
CA1
ATP2A1
4
5
0.0331
0.1501
0.0021
174
AA4
HSPB1
5
5
0.0220
0.0979
7.16E-5
188
CA1
ATP2A1
4
5
0.0331
0.1237
0.0021
258
AA4
HSPB1
5
5
0.0220
0.0743
7.16E-5
277
CA1
ATP2A1
4
5
0.0331
0.1708
0.0021
320
AA4
HSPB1
5
5
0.0220
0.0838
7.16E-5
351
CA1
ATP2A1
4
5
0.0331
0.1814
0.0021
377
AA4
HSPB1
5
5
0.0220
0.0809
7.16E-5
412
CA1
ATP2A1
4
5
0.0331
0.1347
0.0021
248
CLN3
4
7
0.0461
0.1459
0.0116
410
AA4
HSPB1
5
5
0.0220
0.0747
7.16E-5
443
CA1
ATP2A1
4
5
0.0331
0.1159
0.0021
316
CLN3
4
6
0.0396
0.1190
0.0056
142
ECHS1
8
12 0.0519
0.1196
6.55E-5
479
CA1
ATP2A1
4
5
0.0331
0.0988
0.0021
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FDR_OMIM
0.1745
0.0289
0.0023
0.0345
0.0035
0.0384
0.0057
0.0467
0.0067
0.0509
0.1625
0.0078
0.0663
0.1118
0.0096
0.0728

FDR
product
2.77E-02
4.34E-03
2.25E-04
4.27E-03
2.60E-04
6.56E-03
4.78E-04
8.47E-03
5.42E-04
6.86E-03
2.37E-02
5.83E-04
7.68E-03
1.33E-02
1.15E-03
7.19E-03

Table 3.5
Cluster analysis results for HPRDNet and MultiNet
Cluster
Name
HPRDNet AA1
AA2
AA3
CA1
MultiNet AA4
CA1
Network

CNV_AA CNV_CA
HSPB1
HSPB1
HSPB1
HSPB1
-

ATP2A1
ATP2A1

Pathogenic
gene number
8
8
8
4
5
4

Cluster
Size
11
12
13
5
5
5

Figure 3.1 Graph representations of selected clusters for biological significance analysis
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Table 3.6
Selected genes with potential roles in health disparities and their located CNVs
CNV Region
Chr Gene Coordinates
7 75,931,861-75,933,614 75,867,431-76,481,102
75,929,740-76,481,102
75,929,740-76,568,388
ATP2A1 16 28,889,726-28,915,830 28,306,730-28,936,772
Gene
HSPB1
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CNV Type
Duplication
Duplication
Duplication
Duplication

CNV Occurrence
Only in African American
Only in African American
higher in African American than in Caucasian
Only in Caucasian

3.3.1 Clusters enriched with genes located in African American CNVs
We found four similar clusters, (AA1, AA2, and AA3 in HPRDNet and AA4 in
MultiNet), that are enriched both for pathogenic genes and for genes located in AfricanAmerican CNVs (Table 3.5). In HPRDNet, cluster AA1, AA2 and AA3 together were
ranked at first place five times; and cluster AA4 were ranked at first place five times in
Multinet (Table 3.4). Cluster AA1 contains 11 genes, within which eight are pathogenic
genes (Figure 3.1A). Cluster AA2 and AA3 contain one and two more genes than cluster
AA1, respectively (Figure 3.2). In MultiNet, cluster AA4 contains five genes and can be
considered as a sub-cluster of cluster AA1, AA2 and AA3 (Figure 3.1B). All four clusters
contain gene HSPB1 (Table 3.5), which is mainly duplicated in African Americans
(Table 3.6). Since cluster AA1, AA2 and AA3 were selected from the same network and
are highly similar to each other, only cluster AA1 and AA4 were studied in biological
significance analyses.
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Figure 3.2 Graph representations of cluster AA1, AA2 and AA3.

3.3.2 Clusters enriched with genes located in Caucasian CNVs
In both HPRDNet and MultiNet, the same cluster, named as CA1, was identified
to be enriched with both pathogenic genes and genes located in Caucasian CNVs (Table
3.5). Cluster CA1 was ranked at first place four times in HPRDNet (Table 3.3) and seven
times in MultiNet (Table 3.4). This cluster contains five genes, and four of them are
associated with diseases (Figure 3.1C). Cluster CA1 contains gene ATP2A1 which is
duplicated only in Caucasians (Table 3.6).

31

3.4 Plausible Links of population-specific CNVs in the identified Network Clusters
to Health Disparities
To investigate the possible links of population-specific CNVs to heath disparities,
we first identified significantly enriched GO terms that are associated with CNV_AA or
CNV_CA genes in the identified network clusters. We then focus on the pathogenic
genes with the enriched GO terms, and examined their associated disease phenotypes in
OMIM database. The results of GO term enrichment analysis are listed in Table 3.7, and
the associated diseases are listed in Table 3.8.

Table 3.7
Enriched GO terms with CNV-genes in the identified network clusters
Clusters Involved Genes
AA1
HSPB1, CRYAA,
CRYAB,
CRYBB2,
CRYBA1,
CRYBA2
AA4
HSPB1, CRYAA,
CRYAB

HSPB1, CRYAA,
CRYAB, CRYBB2
HSPB1, CRYAB
CA1

ATP2A1,
ATP2A2, PLN
ATP2A1, PLN

GO Domain
Molecular
Function

GO ID
GO term
GO:0042802 Identical protein binding

Biological
Process

GO:0043086 negative regulation of
catalytic activity
GO:0043066 negative regulation of
apoptotic process
GO:0043069 negative regulation of
programmed cell death
GO:0042802 Identical protein binding

Molecular
Function
Cellular
Component
Biological
Process
Biological
Process

GO:0030018 Z disc
GO:0048878 chemical homeostasis
GO:0006937 regulation of muscle
contraction
GO:0008016 regulation of heart
contraction
32

Table 3.8
Associated diseases of genes with enriched GO terms.
Cluster Gene
AA1
HSPB1
and
AA4
CRYAA
CRYAB

CA1

Associated Disease
Axonal Charcot-Marie-Tooth disease type 2F
Distal hereditary motor neuronopathy type 2B
Multiple types of cataract 9
Multiple types of cataract 16
Dilated cardiomyopathy-1II
Myofibrillar myopathy-2
CRYAB-related fatal infantile hypertonic myofibrillar myopathy
CRYBB2 Multiple types of Cataract 3
ATP2A1 Brody myopathy
ATP2A2 Acrokeratosis verruciformis
Darier disease
PLN
Dilated cardiomyopathy-1P
Familial hypertrophic cardiomyopathy-18

3.4.1 Duplication of HSPB1 and Health Disparities in African Americans
Gene HSPB1 is located in genomic duplication regions occurring more frequently
in African Americans (Table 3.6), and is found in the cluster family of AA1, AA2, AA3,
and AA4 (Table 3.5). For cluster AA1, only one GO molecular function term related to
gene HSPB1 is significantly enriched (Cluster AA1 in Table 3.7). For cluster AA4, in
addition to the same enriched GO molecular functions term, three more GO biological
process terms and one GO cellular component term are found significantly enriched
(Cluster AA4 in Table 3.7). In the genes with the enriched GO terms, four of them are
known to be associated with diseases (Cluster AA1/AA4 in Table 3.8). Among these four
genes, three of them are implicated in health disparities of African Americans.
Specifically, gene CRYAB is related to dilated cardiomyopathy and myofibrillar
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myopathy. African Americans were found at higher risk for idiopathic dilated
cardiomyopathy compared with Caucasian, and this could not be explained by income,
education, alcohol use, smoking, or history of some other diseases (Coughlin et al. 1993).
Moreover, gene CRYAA, CRYAB and CRYBB2 are all related to various types of cataract.
It was reported that age-specific blindness prevalence was higher for African Americans
compared with Caucasian, and cataract accounts for 36.8% of all blindness in African
American, but for only 8.7% in Caucasian (Congdon et al. 2004).
We would like to emphasize that gene HSPB1 is located in three CNVs that occur
frequently in African Americans. Our results predict that HSPB1 is a potential causal
gene in these CNVs for health disparities. How could HSPB1 duplication contribute to
health disparity? Based on the direct interaction between HSPB1 and CRYAB and the fact
that both genes are expressed in Z-disc (Table 3.7), it is plausible that HSPB1 may play
an unknown role in cardiomyopathy. Alternatively, HSPB1 might be involved in cataract,
because HSPB1, CRYAA and CRYAB interact with each other and all can negatively
regulate apoptotic process (Table 3.7). Studies suggested that lens epithelial cell
apoptosis may be a common cellular basis for initiation of non-congenital cataract
formation (Li et al. 1995), and inhibition of epithelial cell apoptosis may be one possible
mechanism that inhibits cataract development (Nahomi et al. 2013). Our results here
argue for further experimental studies to test the possible role of HSPB1 CNVs in
cardiomyopathy or cataract/blindness in African Americans.
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3.4.2 Duplication of ATP2A1 and Health Disparities in Caucasians
Gene ATP2A1 in cluster CA1 is located in a genomic duplication region that
occurs only in Caucasians (Table 3.6). We found that three genes in cluster CA1 are
enriched with various GO biological process terms that involve ATP2A1 (Cluster CA1 in
Table 3.7). All of the three genes are related to diseases when they mutated (Cluster CA1
in Table 3.8). Our results here predict that APT2A1 is a candidate causal gene for health
disparity in this region.
How would ATP2A1 influence health disparity? Among the diseases related to the
pathogenic genes in cluster CA1, idiopathic dilated cardiomyopathy occurs less often in
Caucasians than in African Americans (Coughlin et al. 1993). One possibility is that
higher copies of ATP2A1 may offer some benefits to Caucasians. Studies have shown that
increased activity of sarco/endoplasmic reticulum Ca2+-ATPase 1 (SERCA1), which is
encoded by ATP2A1, can partially rescue the heart from •OH-induced injury
(Hiranandani et al. 2006), and protect the heart from ischemia-reperfusion (I/R) injury
(Talukder et al. 2007). Another possibility is that higher copies of ATP2A1 only lead to
moderate risk of cardiomyopathy in Caucasians, and this moderate effect is
overshadowed by other genetics factors not covered by our CNV dataset.
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CHAPTER IV
CONCLUSION

In this study, we proposed a network clustering based approach to associate
CNVs to health disparities in African and American. Gene clusters were inferred from
two human gene/protein networks, HPRDNet and MultiNet, by MCL clustering
algorithm with different parameters. Each cluster was ranked based on products of FDR
values obtained from the right-tailed Fisher’s exact tests for enrichment of pathogenic
genes or CNV-genes. Five clusters were consistently found to be ranked at first place and
be enriched with both pathogenic genes and genes located in African-American or
Caucasian CNVs. In cluster AA1, AA2, AA3 and AA4, gene HSPB1 is located in
African-American-specific CNVs that are duplicated more frequently in AfricanAmericans. In clusters CA1, gene ATP2A1 is located in a Caucasian-specific CNV that is
duplicated only in Caucasians. All gene clusters are associated with certain diseases that
occur more often in one population than in the other, which could be considered as results
of the occurrence of corresponding CNVs. Although we only studied populationdifferential CNVs and did not consider the roles of other genetic factors, our
computational studies have generated some interesting hypotheses for further
experimental studies to understand health disparities in these diseases.
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// Setup connection to UCSC Genome Database
String username = "genome";
String password = "";
String url = "jdbc:mysql://genome-mysql.cse.ucsc.edu/hg19";
Class.forName("com.mysql.jdbc.Driver");
Connection con = DriverManager.getConnection(url, username, password);
Statement stmt = con.createStatement();
ResultSet rs = null;
// Search for gene names by SNP id
// Compose and submit SQL statements to UCSC Genome Database
rs = stmt.executeQuery(
"select distinct S.name, X.geneSymbol " +
"from snp138 as S, knownGene as G, kgXref as X " +
"where S.name = '" + "rs" + new_snp + "' AND X.kgId = G.name AND
S.chrom = G.chrom AND " + "G.txStart <= S.chromStart AND
G.txEnd >= S.chromEnd;");
// extract results and write to output file
if (rs.next()){
do {
for (int i=1; i<3; i++) { output.print(rs.getString(i)+"\t"); }
output.println();
}while (rs.next());
}
else { output.println("rs" + new_snp + "\t" + "gene_not_found"); }
// Search for gene names by CNV loci
// Compose and submit SQL statements to UCSC Genome Database
rs = stmt.executeQuery(
"select distinct X.geneSymbol, G.chrom, G.txStart, G.txEnd " +
"from knownGene as G, kgXref as X " +
"where ((G.txStart>" + begin + " AND G.txEND<"
+ end + ") or "
"(G.txStart>" + begin + " AND G.txStart<" + end + ") or "
"(G.txEND>"
+ begin + " AND G.txEND<"
+ end + ") or "
"(G.txStart<" + begin + " AND G.txEnd>"
+ end + ")) AND
"X.kgId = G.name AND G.chrom = '" + chrom + "';");

+
+
+
" +

// extract results and write to output file
if (rs.next()) {
do {
for (int l=1; l<5; l++) { output.print(rs.getString(l)+"\t"); }
output.println();
}while (rs.next());
}
else { output.println("not found"); }
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//setup R engine
Rengine re = new Rengine (new String[] {}, false, null);
// Check if the session is working.
if (!re.waitForR()) { return; }
//Fisher's exact test for OMIM genes
for (int k=1; k<=nCluster; k++)
{
if(AA_GeneClusters[k].get_q() != 0)
{
// obtain values and create the contingency table
double cluster_q = AA_GeneClusters[k].get_q();
double cluster_m = AA_GeneClusters[k].get_m();
double cluster_nonOMIM = cluster_m - cluster_q;
double other_OMIM = Q - cluster_q;
double other_nonOMIM = N - Q - cluster_nonOMIM;
re.eval("cluster = c("+cluster_q+","+cluster_nonOMIM+")");
re.eval("other = c("+other_OMIM+","+other_nonOMIM+")");
re.eval("tb = rbind(cluster, other)");
// perform the Fisher’s exact test and obtain the p-value
double p_OMIM = re.eval("fisher.test(tb,
alternative=\"greater\")$p.value").asDouble();
}
}
//Fisher’s exact test for AA and CA genes
for (int k=1; k<=nCluster; k++)
{
double cluster_AA_s = AA_GeneClusters[k].get_s();
double cluster_CA_s = CA_GeneClusters[k].get_s();
double cluster_m = AA_GeneClusters[k].get_m();
double other_AA = S_AA - cluster_AA_s;
double other_CA = S_CA - cluster_CA_s;
// Fisher's exact test for AA only
if(AA_GeneClusters[k].get_s() != 0)
{
// obtain values and create the contingency table
double cluster_nonAA = cluster_m - cluster_AA_s;
double other_nonAA = N-cluster_m-S_AA+cluster_AA_s;
re.eval("cluster = c("+cluster_AA_s+","+cluster_nonAA+")");
re.eval("other = c("+other_AA+","+other_nonAA+")");
re.eval("tb = rbind(cluster, other)");
// perform the Fisher’s exact test and obtain the p-value
double p_AA = re.eval("fisher.test(tb,
alternative=\"greater\")$p.value").asDouble();
}
// Fisher's exact test for CA only
if(CA_GeneClusters[k].get_s() != 0)
{
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// obtain values and create the contingency table
double cluster_nonCA = cluster_m - cluster_CA_s;
double other_nonCA = N-cluster_m-S_CA+cluster_CA_s;
re.eval("cluster = c("+cluster_CA_s+","+cluster_nonCA+")");
re.eval("other = c("+other_CA+","+other_nonCA+")");
re.eval("tb = rbind(cluster, other)");
// perform the Fisher’s exact test and obtain the p-value
double p_CA = re.eval("fisher.test(tb,
alternative=\"greater\")$p.value").asDouble();
}
}
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APPENDIX C
CODES FOR FALSE DISCOVERY RATE CALCULATION
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// Calculate FDR values
//fp is the File object of input file
Scanner pScan = new Scanner(fp);
//RstatementA contains a R statement to create a tuple of all p-values.
String RstatementA = "p=c(";
while (pScan.hasNextLine())
{
String line = pScan.nextLine();
Scanner lineReader = new Scanner(line);
lineReader.next();
int tmp = (int) lineReader.nextDouble();
if (tmp != 0)
{
lineReader.next();
double p = lineReader.nextDouble();
RstatementA = RstatementA + p + ", ";
log.println("RstatementA"+RstatementA);
}
}
RstatementA = RstatementA.substring(0, RstatementA.length()-2) + ")";
// create a tuple named “p”
re.eval(RstatementA);
// load robust-fdr routine
re.eval("source(\"D:/eclipse/workspace/test/robust-fdr.R\")");
// RstatementD contains a R statement to run robust-fdr routine
String RstatementD = "robust.fdr(p, discrete=T, use8=F)$fdr";
// Obtain fdr values and save to an array
double[] fdr_disc = re.eval(RstatementD).asDoubleArray();
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